Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
Each points toward different possible causes
For physicians: How to request single patient expanded access (Compassionate use)
Subcutaneous injection near the injury site is the standard administration method for musculoskeletal indications because proximity to the damaged tissue maximizes the local angiogenic effect
They replenish your stores quickly
FASEB Journal (1997) 7
US$ 23.75
US$ 24.90
US$ 29.39
US$ 24.23
US$ 28.92
